Awards & Advancement

PPD names David Johnston executive vice president

Tuesday, August 13, 2013 11:30 AM

CRO Pharmaceutical Product Development (PPD) has appointed David Johnston, Ph.D., executive vice president of global laboratory services. Johnston directs PPD’s comprehensive laboratory services, including bioanalytical, vaccines and biologics, current good manufacturing practice (cGMP) and central laboratories.

More... »

Anne Lindblad promoted to president and CEO of EMMES

Monday, August 12, 2013 04:18 PM

EMMES has promoted executive vice president Dr. Anne Lindblad to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein, who has been named past president. Stablein, who joined the company in 1980, has been president/CEO since 1992. In his new role as past president, he will continue to provide project support and will be an ambassador for EMMES.

More... »

inVentiv Health Clinical expands executive team

Friday, August 9, 2013 02:02 PM

CRO inVentiv Health Clinical has appointed Dawn Anderson president of phase II-IV development, Martin Birkhofer chief medical officer and Richard Shimota chief financial officer.

More... »

Harlan CRS Cytotest Cell Research in EU-NETVAL

Friday, August 9, 2013 01:58 PM

Germany-based Harlan Contract Research Services (CRS) Cytotest Cell Research has been selected for inclusion in the E.U. Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL). EU-NETVAL provides support for the E.U. Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) to develop methods to reduce, refine or replace animals used for scientific purposes.

More... »

Alan Copa joins Novum as vice president

Friday, August 9, 2013 01:56 PM

Dr. Alan Copa has joined the leadership team of CRO Novum Pharmaceutical Research Services as vice president. Previously, Copa was chief scientific officer of PRACS Institute. In his 20-year tenure at the company, Copa had numerous clinical and operational lead roles, and was Principal Investigator on 1,000 projects spanning early phase, dermatology and pharmacokinetics.

More... »

CFS Clinical named one of best places to work

Wednesday, August 7, 2013 11:57 AM

Philadelphia Business Journal has named CFS Clinical, a specialty provider focused on the business and financial management activities for clinical trials, one of its Best Places to Work in the Philadelphia region for the second year in a row. The award recognizes the company’s achievements in creating a positive work environment that attracts and retains employees through a combination of benefits, working conditions and company culture.

More... »

Astellas appoints senior vp of global oncology development

Tuesday, August 6, 2013 11:30 AM

Tokyo-based Astellas Pharma Global Development has appointed Claire Thom senior vice president of global oncology development.

More... »

Arisaph awarded phase I STTR grant

Tuesday, August 6, 2013 11:06 AM

Arisaph Pharmaceuticals, a privately held drug discovery and development biopharmaceutical company focused on developing novel therapies for cardiometabolic diseases and cancer, has been awarded a phase I Small Business Technology Transfer (STTR) award from the National Cancer Institute of the NIH. The award supports the R&D of Arisaph's small molecule immune modulators to stimulate tumor immunity following treatment with BRAF inhibitors in cancer.  

More... »

Moderna Therapeutics names Joseph Bolen president of R&D

Thursday, August 1, 2013 12:27 PM

Moderna Therapeutics, developing messenger RNA therapeutics, a new treatment modality to enable the in vivo production of therapeutic proteins, has hired Joseph Bolen, Ph.D., as its president of R&D.

More... »

DIA names Barbara Lopez Kunz global chief executive

Thursday, August 1, 2013 12:00 PM

DIA, a neutral, global, professional member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related healthcare products, has named Barbara Lopez Kunz global chief executive, to lead the organization beginning in September. Kunz brings worldwide leadership experience to DIA as former president of the global health and life sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology and manages laboratories.

More... »